DNA-PK is a nuclear, serine/threonine protein kinase required for repairing DNA double-strand breaks and for V(D)J recombination. To determine the distribution of DNA-PK in human tissues, we assayed paranembedded sections of normal and cancerous tissues for DNA-PK cs and Ku80 by immunohistochemistry. We also assayed for Brca2, a human tumor suppressor gene that is implicated in the repair of DNA strand-breaks. Brca2 was strongly expressed in epithelial cells of the breast, endometrium, and thymus, in tingible body macrophages of follicular germinal centers of lymphoid tissue, and in reticuloendothelial cells in the spleen. DNA-PK cs and Ku80 expression was usually parallel, but both were expressed in a highly cell-and tissue-speci®c manner. The highest levels were observed in spermatogenic cells (but not in spermatozoa), and in neurons and glial cells of the central and autonomic nervous system. Neither protein was consistently expressed in liver nor in resting mammary epithelium, but lactating breast epithelium was strongly positive for DNA-PK cs and Ku80. In contrast to established human cell cultures, expression between cells in the same tissue was highly selective in the epidermis, exocrine pancreas, renal glomeruli, the red pulp of the spleen, and within cellular compartments of tonsils, lymph nodes, and thymus. Most cancerous tissues were consistently positive for DNA-PK cs and Ku80, except invasive carcinoma of the breast. DNA-PK cs , Ku80, and Ku70 mRNAs were expressed in all normal tissues with relatively little variation in levels. Our results suggest that the apparent absence of DNA-PK cs and Ku80 from some cells or tissues is a consequence of posttranscriptional mechanisms that regulate protein levels.
Introduction
The integrity of a cell's DNA is of paramount importance for survival; therefore, all living cells have evolved mechanisms for repairing DNA lesions (Friedberg et al., 1995) . Double-strand breaks (DSBs) are among the most critical lesions in chromosomal DNA (reviewed in Chu, 1997; Iliakis, 1991; Pfeier et al., 1996) . A single unrepaired DSB will result in a broken chromosome and cell death, while misrepaired DSBs may cause chromosome rearrangements that can lead to cancer. DSBs occur spontaneously at a low rate from natural chemical reactions and enzymatic errors (Bernstein and Bernstein, 1991) , and they may be induced by a variety of natural and man-made agents such as free radicals and ionizing radiation. Many anticancer drugs also directly or indirectly produce DSBs, and these are believed to be the primary lesions responsible for cell death (Eastman and Barry, 1992) .
Although the biochemical mechanisms for repairing DSBs in mammalian cells are still poorly understood, substantial progress has been made in the last few years, and at least two repair pathways have been identi®ed (reviewed in Chu, 1997; Hendrickson, 1997; Petrini et al., 1997) . In single-celled organisms, such as the yeast Saccharomyces cerevisiae, the major pathway for DSB repair involves recombination with a homologous region, usually the undamaged sister chromatid; this pathway is accomplished primarily by the eleven proteins that comprise the RAD52 epistasis group (RAD50-57, RAD59, MRE11, XRS2). Human and rodent homologs of at least ®ve yeast genes in the RAD52 epistasis group, including RAD50, RAD51, RAD52, RAD53, and MRE11 have been cloned, and transcripts of these genes have been detected in nearly all tissues examined (Kanaar et al., 1996; Muris et al., 1994; Petrini et al., 1995; Shinohara et al., 1993) . However, expression at the mRNA level of several of these genes is enhanced in certain dierentiated tissues such as spermatogonia, spermatocytes, ovarian follicle cells, resting oocytes (Kanaar et al., 1996; Yamamoto et al., 1996) and the testis (Dolganov et al., 1996; Kanaar et al., 1996; Muris et al., 1994; Petrini et al., 1995) . Over-expression of human RAD52 increases resistance to ionizing radiation as well as the frequency of homologous recombination (Park, 1995) , while mouse embryonal stem (ES) cells with a homozygous disruption in the RAD54 gene are hypersensitive to ionizing radiation (Essers et al., 1997) , observations suggesting a role for RAD52 epistasis gene products in DSB repair. RAD52 epistasis group proteins are also expressed at high levels in lymphopoietic tissues including the spleen and thymus, indicating that they may be involved in lymphogenesis (Dolganov et al., 1996; Kanaar et al., 1996; Muris et al., 1994; Yamamoto et al., 1996) . V(D)J recombination and immunoglobulin class switching, two recombinational events that occur in lymphoid development, require the processing of DSBs (Gellert, 1994; Smider and Chu, 1997; Weaver et al., 1995) .
In multicellular eukaryotes, the predominant pathway for DSB repair involves a distinct end-joining pathway that requires little or no sequence homology (Chu, 1997) . Four gene products required for this activity have been identi®ed, three of which, DNA-PK cs , Ku70 and Ku80, correspond to the three subunits of the DNA-activated protein kinase, DNA-PK (reviewed in Anderson and Carter, 1996; Anderson and Lees-Miller, 1992; Dynan and Yoo, 1998) . DNA-PK is the prototype of a family of large, nuclear, serine/threonine protein kinases that are involved in DNA damage signaling and cell cycle control but which are related to phosphatidylinositol kinases (Carpenter and Cantley, 1996; Hunter, 1995; Keith and Schreiber, 1995) . The fourth component, XRCC4, is a 55 ± 60 kDa nuclear phosphoprotein that is ubiquitously expressed and forms tight complexes with DNA ligase IV (Critchlow et al., 1997; Leber et al., 1998; Li et al., 1995) . In vitro DNA-PK is activated by DNA strand breaks and other DNA structures involving single-to-double strand transitions (Morozov et al., 1994) , strongly suggesting a role for DNA-PK in repairing DNA DSBs. The catalytic subunit, DNA-PK cs is a large, nuclear polypeptide (4127 amino acids) that is moderately abundant in cultured human cells Carter et al., 1990; Lees-Miller et al., 1990) . Ku is a heterodimeric protein of 70 and 80 kDa polypeptides that also is abundant in the nuclei of cultured human cells (Mimori et al., 1986) . Ku binds DNA ends (Blier et al., 1993; Falzon et al., 1993) and targets DNA-PK cs to DNA strand breaks (Gottlieb and Jackson, 1993; Suwa et al., 1994) , where the kinase is presumed to activate or regulate the components that repair DSBs (Chu, 1997) . Rodent cells with defects in the genes for each of the DNA-PK components or in XRCC4 are sensitive to ionizing radiation and other agents that cause DNA strand breaks, and they also are defective in DSB repair (Gu et al., 1997; Thompson and Jeggo, 1995, and references therein) . Mutations in the mouse DNA-PK cs gene (PRKDC) are responsible for the severe combined immunode®ciency (SCID) phenotype, and cells with mutations in the genes for DNA-PK cs , Ku, or XRCC4 are defective in the recombination of variable (V), diversity (D) and joining (J) germline segments required for rearranging functional immunoglobulin and T-cell receptor genes. Mice with a complete loss of DNA-PK cs expression develop thymic lymphoblastoid lymphomas, indicating that DNA-PK-mediated DSB repair is important for preventing this type of cancer (Jhappan et al., 1997) . Arabian foals with a homozygous defect in the DNA-PK cs gene develop normally but die shortly after birth from infections because they lack a functional immune system (Shin et al., 1997; Wiler et al., 1995) ; however, mutations that aect DNA-PK activity in humans have not been identi®ed. Brca2 is another large, nuclear protein (3418 amino acids) that is expressed at high levels in rapidly dividing cells (Casey, 1997; Rajan et al., 1996; Suzuki et al., 1997; Tavtigian et al., 1996) . BRCA2 and BRCA1 are coordinately expressed, and both form complexes with Rad51 (Scully et al., 1997; Sharan et al., 1997) . Recently, a direct role for Brca2 in repairing double-strand breaks was demonstrated (Abbott et al., 1998; Bertwistle and Ashworth, 1998; Connor et al., 1997) .
Although DNA-PK is a relatively abundant protein kinase in all cultured human cells that have been examined (e.g. Anderson and Lees-Miller, 1992), its expression in normal and cancerous human tissues has not been examined. We, therefore, initiated a study to characterize the expression of DNA-PK cs and Ku80, two components of the DNA-PK holoenzyme, in a wide spectrum of dierent human tissues using highly speci®c antibodies. We also examined these tissues for expression of the Brca2 tumor suppressor protein. Surprisingly, in contrast to human tissue culture cells, we found that several tissues and cell types expressed little if any of DNA-PK cs . All tissues that expressed DNA-PK cs also expressed Ku80. Testis, brain, and the autonomic nervous system exhibited the highest levels of DNA-PK cs protein. In contrast, DNA-PK cs and Ku mRNA expression levels were virtually invariant with respect to tissue, suggesting that tissue-speci®c expression is a consequence of post-transcriptional eects. Importantly, however, our results suggest that human tissues may not be equally pro®cient in non-homologous DNA double-strand break repair.
Results
To validate the speci®city of our previously generated DNA-PK cs antisera, which detects epitopes between amino acids 2015 and 2134 in the human DNA-PK cs sequence, we ®rst examined by immuno¯uorescence the expression of DNA-PK cs in a pair of related glioblastoma-derived human tumor cell lines, M059J that does not express DNA-PK, and M059K which does (Lees-Miller et al., 1995) . The M059K cell line expressed high levels of an immuno-reactive protein that gave a pattern of bright, exclusively nuclear uorescence, as do virtually all cultured human cells that we and others have examined (Figure 1a ). In contrast, no nuclear staining was observed in M059J cells ( Figure 1b) ; these cells also express little if any DNA-PK cs mRNA (Lees-Miller et al., 1995) . Weak staining of perinuclear structures slightly brighter than the background staining was observed with preimmune serum (Figure 1c and d) ; the signi®cance of this is unclear. The strong nuclear pattern observed with this antiserum is highly speci®c for DNA-PK cs as was shown previously by Western blotting (Connelly et al., 1998) . We also used commercial antisera that are highly speci®c for the 80 kDa component of Ku and for the Brca2 protein (see Materials and methods).
Protein expression in normal epithelial tissues
To assess DNA-PK cs , Ku80, and Brca2 expression in individual cells from a wide variety of normal human tissues, we examined paran-embedded sections after immunohistochemical staining with antibodies speci®c for each of the three proteins. Micrographs of sections of dierent normal tissues are shown in Figures 2 and  3 , and semi-quantitative summaries of our results are presented in Tables 1 and 2 . While no signi®cant staining by DNA-PK cs and Ku80 was seen in liver ( Figure 2f ) and resting breast tissue (Figure 2b ), a variable but signi®cant fraction of cellular nuclei stained intensely for DNA-PK cs and Ku80 in most human tissues including colon, pancreas, kidney, endometrium, prostate, testis (seminiferous tubules), epididymis, brain, intestinal autonomic nerve ganglia, and skin ( Figure 2 , Table 1 ). Importantly, a striking cell-to-cell speci®city was observed within each tissue. In epithelial tissues, the epithelial cells themselves generally expressed DNA-PK cs and Ku80 at much higher frequency than did their stromal cells. For example, more than 80% of epithelial cell nuclei in the colon (Figure 2a (Table  1) . A strict cell-type speci®city of DNA-PK cs expression, even within parenchymal cells, is exempli®ed by the renal glomerulus of the kidney. Forty per cent of epithelial and endothelial cells strongly expressed DNA-PK cs and Ku80, whereas mesangial cells were virtually negative for both (Figure 2d ). Another example is the ovary. While the ovarian surface epithelium, follicular epithelium, ovarian stroma, and rete ovarii are devoid of DNA-PK cs expression, the nuclei of luteinizing stromal cells, a scant hormonedependent, androgen-producing cell type in the ovarian stroma, were positive (Figure 2k ). This also was the only cell type in the ovary that stained positively for Brca2. Within cells of the same type, variability in the intensity of DNA-PK cs expression was seen in virtually all epithelial cells of the colon, prostate, epididymis, Islets of Langerhans, and renal collecting ducts. In other tissues, e.g., the epithelial and endothelial cells of the renal glomerulus (Figure 2d ), cortical renal tubular epithelium (not shown), endometrial glands (Figure 2i) , and acinar cells of exocrine pancreas (Figure 2g ), DNA-PK cs expression was restricted to less than half of the cells of the same type. Likewise, in UV exposed skin, DNA-PK cs and Ku80 (Figure 2p ) expression was present in discrete keratinocytes in all layers except the stratum corneum while, surprisingly, adjacent keratinocytes were complete negative ( Figure 2p , see arrows). All cell types that expressed DNA-PK cs also expressed the 80 kDa subunit of Ku.
A notable exception to the rule that DNA-PK cs is expressed in most epithelial tissues was normal mammary epithelium in a non-secretory (resting) state from pre-and post-menopausal women ( Figure  2b ). The luminal epithelial cells of the breast, which are in a G 0 state, were virtually devoid of DNA-PK cs expression, but staining was observed in about 30% of stromal cells. Epithelial cells from the resting breast Figure 1 Detection of DNA-PK cs by immuno¯uorescence. Human M059K glioblastoma cells stained with the DNA-PK cs -speci®c antiserum AB-145 showed bright nuclear¯uorescence (a) while M059J cells, which do not express DNA-PK cs , showed no nuclear staining (b). In neither cell line were nuclei stained with preimmune serum (c, M059K; d, M059J). Cells were photographed under epi¯uorescent illumination at 406 also were negative for Ku80 (but see Table 1 , footnote c) and strongly positive for Brca2; stromal cells exhibited weak staining for Ku80, while a fraction also were positive for Brca2 (data not shown, see Table 1 ). This ®nding is in sharp contrast to lactating, active mammary epithelium in which over 80% of luminal epithelial cells exhibited very strong nuclear DNA-PK cs and Ku80 expression ( Figure 2c ). DNA-PK cs thus is an example of an enzyme whose expression changes dramatically with change in physiological state, in this case when the tissue undergoes hormone-dependent proliferation and terminal dierentiation.
The highest levels of DNA-PK cs expression were found in testis and in central and autonomic nerve tissue (Table 1; Figure 2 , l, m, q, r). Cells in the early stages of spermatogenesis (spermatogonia, spermatocytes and spermatids, but not spermatozoa) were among the highest expressors of DNA-PK cs , suggesting that DNA-PK cs expression is downregulated after both meiotic divisions are completed. Likewise, non-spermatogenic Sertoli cells, which provide nutritional and mechanical support to the developing spermatogones, as well as stromal testosterone-producing Leydig cells, were negative for DNA-PK cs and Ku80 expression (Figure 2, l and m, see arrows). Many, but not all, cortical neurons in the gray matter and in the subcortical white matter stained strongly positive for DNA-PK cs ( Figure 2r ) and Ku80 (Table 1) . Pyramidal neurons in the motor cortex were, however, DNA-PK cs negative. A signi®cant subset of glial cells in the grey and white matter also stained strongly positive for DNA-PK cs and Ku80 (Table 1) . Most of these were astrocytes with a smaller fraction being oligodentrocytes; however, many astrocytes were completely negative (Figure 2r , arrows). Microglia were always negative for DNA-PK cs and Ku80. Parasympathetic ganglia, as well as myelin-producing Schwann cells of the autonomic nervous system, also were strongly positive for DNA-PK cs and Ku80. An example is shown in the myenteric plexus of the large intestine (Figure 2q , arrows point to neurons).
Brca2 was expressed in about half of the tissues examined, most notably in mammary epithelium of the resting breast, but also in epithelial cells of the endometrium, luteinizing stromal cells of the ovary, acinar cells of the pancreas, Islets of Langerhans of the pancreas, and epithelial and endothelial cells of the renal glomerulus, and in very focal clusters of hepatocytes of the liver. Other tissues were not signi®cantly stained for Brca2; these included colonic epithelium, mesangial cells of the renal glomerulus, epithelial and stromal cells of the prostate, ovary, spermatogenic and stromal cells of the testis, neurons and glial cells of the brain, and keratinocytes of the skin.
Protein expression in normal lymphoid tissues
DNA-PK cs , Ku80, and Brca2 expression were examined in tonsils, lymph nodes, spleen, and thymus as examples of lymphoid tissues ( Figure 3 , Table 2 ). A discrete compartmentalization of DNA-PK cs and Ku80 expression was found in lymphoid follicles of tonsils (Figure 3a and b) . The majority of immunoblasts in the germinal centers of lymphoid follicles were strongly positive for DNA-PK cs while fewer cells were weakly positive for Ku80 and Brca2 (Figure 3a ± c) . Follicular center macrophages were negative for DNA-PK cs and Ku80, but strongly positive for Brca2 (Figure 3c , see arrows). The majority of resting B cells that make up the surrounding mantle zone were negative for all three proteins. Within the mantle zone, DNA-PK cs positivity was restricted primarily to dendritic cells (Figure 3a , right portion of panel). Dendritic cells in T cell-rich interfollicular areas also were strongly positive for DNA-PK cs expression, and these same cells were moderately positive for Ku80 expression (data not shown). In spleen, DNA-PK cs and Ku80 expression was observed mainly within the red pulp. Many but not all reticuloendothelial cells that line the blood-®lled sinusoidal spaces strongly expressed DNA-PK cs ( Figure  3d , see arrows) while macrophages and lymphoid cells were negative. Expression of Brca2 (Figure 3f ) paralleled DNA-PK cs and Ku80 expression in these cells. In the white pulp, expression of all three proteins was much less prominent (data not shown). In thymus of young children, DNA-PK cs , Ku80 and Brca2 expression was prominent in thymic epithelial cells of the cortex and medulla including Hassall's corpuscles (Figure 3g ± i, and data not shown). In contrast, lymphoid cells in the cortex and medulla showed poor or no expression of DNA-PK cs and Ku80. Macrophages throughout the thymus stained strongly for Brca2 (Figure 3i ). In two of ®ve cases, the mammary epithelium stained for DNA-PK cs and/or Ku80. In one of these, DNA-PK cs staining was weak while Ku80 was strongly expressed in virtually all cells; in the other, DNA-PK cs staining was negative while Ku80 was expressed in *50% of mammary epithelial cells in an interspersed manner. The remaining three patients were negative for both DNA-PK cs and Ku80.
d In three of ®ve cases, staining for DNA-PK cs and Ku in normal liver were totally negative; in two cases, staining for DNA-PK cs was focally positive, but staining for Ku was negative. 
Protein expression in invasive and non-invasive human neoplasms
The above results suggest that expression of DNA-PK cs and Ku80 is cell type and tissue speci®c and that expression levels can change as a consequence of physiological changes, as exempli®ed by breast tissue during lactation. To determine if expression levels also change as a consequence of the changes that accompany malignant cell transformation, we examined DNA-PK cs , Ku80, and Brca2 expression in a spectrum of cancerous tissues. Examples are given in Figure 4 , and our results are summarized in Table 3 .
Although only a limited number of tumors were examined, in general, the expression of each of the three proteins in cancerous tissues paralleled expression in the corresponding normal tissue. This observation pertains to both invasive carcinomas and pre-invasive lesions. The highest levels of DNA-PK cs and Ku80 expression were observed in the malignant germ cells of testicular seminoma (Figure 4l and m) . DNA-PK cs was exclusively expressed in malignant germ cells and not in accompanying benign lymphocytes (Figure 4l , see upper right corner). A Pagetoid-like spread of strongly DNA-PK cs positive seminoma cells also was observed within the benign epithelium of rete testis (Figure 4m , see arrows); embryonal carcinoma showed a weaker expression of DNA-PK cs and Ku80. In colonic adenomatous polyps, strong positive staining for DNA-PK cs was observed in 100% of nuclei of dysplastic epithelial cells and in a signi®cant fraction of stromal cells (Figure 4a ). Ubiquitous nuclear expression of DNA-PK cs and Ku80 also was seen in 100% of malignant epithelial cells of serous carcinoma of the endometrium (Figure 4h ), primary peritoneal carcinoma (Figure 4i ), prostate carcinoma in situ (Figure 4j) , and invasive carcinoma of the prostate (Figure 4k ). Weaker but ubiquitous staining of DNA-PK cs was observed in 100% of malignant B-cells in Burkitt's lymphoma (data not shown) and in 490% of malignant lymphoid cells in cutaneous lymphoma ( Figure 4o) ; in contrast, benign lymphocytes admixed with malignant tissues did not express detectable amounts of any of the three proteins (e.g. Figure 4l and o).
Interestingly, in breast, foci of malignant epithelium expressing DNA-PK cs and Ku80 were observed in carcinoma in situ (Figure 4d and e), but invasive carcinoma lacked consistent expression of any of the three proteins (Figure 4f and g ). In contrast, 100% of malignant epithelial cells of invasive colon carcinoma were strongly positive for DNA-PK cs (Figure 4c ), paralleled by a weaker staining of Ku80 (Figure 4b ). For the tumor tissues examined, with the exception of invasive carcinoma of the breast and serous carcinoma of the endometrium, most did not express Brca2. Admixed normal macrophages, however, were strongly Brca2 positive, as seen in benign lymphoid tissues.
RNA expression in normal tissues
To examine DNA-PK expression at the level of transcription, a commercial blot of polyA-selected RNAs from 50 dierent normal tissues, calibrated for equal loading (see Materials and methods) were probed with speci®c, labeled, single-stranded, 40 base oligonucleotide probes corresponding to anti-sense sequence segments near the 3' ends of DNA-PK cs , Ku70, Ku80, and, as a control, GAPDH. Figure 5 shows RNA levels for selected tissues. A distinct signal, well above background, was observed for each tissue with each probe. Overall, dierences in DNA-PK cs , Ku80, or Ku70 RNA levels between tissues were modest with only a few tissues exhibiting dierences of more than twofold from the 50-tissue average. Because the RNA content may have changed between hybridizations, the levels of the dierent mRNAs cannot be precisely compared; however, Ku70 and Ku80 mRNA levels appeared to be similar to each other and two-to fourfold greater than DNA-PK cs mRNA levels. GAPDH mRNA levels were 20-to 80-fold greater than DNA-PK cs mRNA levels. Although the apparent levels of DNA-PK cs , Ku70, and Ku80 mRNAs in the testis were somewhat higher (1.3 ± 1.8-fold) than the average for all tissues, in apparent correspondence with protein levels in seminiferous tubules, they were slightly lower than this average in the cerebral cortex ( Figure  5 ), even though astrocytes and neurons also expressed high levels of these proteins. We note, however, that tissue-to-tissue variation in apparent levels of GAPDH mRNA, one of ®ve control mRNAs used in the equalization procedure, exhibited greater dierences than the mRNA levels of Ku70, Ku80, or DNA-PK cs . Thus, these apparent small dierences in levels are of doubtful signi®cance.
Discussion
DNA-PK is a nuclear serine/threonine protein kinase required for recombination of V, D, and J immunoglobulin gene segments during the development of the immune system (Dynan and Yoo, 1998; Gellert, 1994; Jackson and Jeggo, 1995) , for immunoglobulin class Among three breast carcinoma cases, two were either completely negative or 51% of malignant cells showed positivity for DNA-PK cs and Ku80; in the third case, malignant cells showed dispersed positivity for DNA-PK cs .
e Macrophages only DNA-PK and Brca2 expression in human tissues U Moll et al 3121 switching (Rolink et al., 1996) , and for non-homologous DNA double-strand break repair (Chu, 1997; Hendrickson, 1997) . The role of DNA-PK in these processes most likely is similar, and probably involves regulating the assembly and/or activity of the protein complexes that repair DNA double-strand breaks. DNA-PK may have other roles in the cellular responses to DNA damage, for example, in regulating p53 Woo et al., 1998) and replication protein A (Brush et al., 1994; Zernik-Kobak et al., 1997) , and in transcription (Barlev et al., 1998; Chibazakura et al., 1997; Dvir et al., 1993; Kuhn et al., 1995; Labhart, 1995) , but while DNA-PK phosphorylates a number of nuclear DNA-binding proteins in vitro, direct roles for DNA-PK in processes other than DSB repair have not been demonstrated.
Previous studies indicate that DNA-PK activity and DNA-PK cs protein is expressed at moderately high levels (compared to many protein kinases) in secondary human ®broblasts and in all established human cell lines examined . Levels of Ku protein were reported to remain constant during the cell cycle in several human cell lines (Li and Yeh, 1992) ; however, steady-state levels of Ku mRNA were reported to be about tenfold higher in cultured human cells compared to human tissues (Cai et al., 1994) . Previous studies also reported that Ku mRNA levels increased dramatically in human peripheral blood lymphocytes stimulated to proliferate in culture (Cai et al., 1994; Yaneva and Jhiang, 1991) ; however, total cellular DNA-PK activity remained constant (Nagasawa et al., 1997) . In contrast to human cells, DNA-PK activity and DNA-PK cs and Ku proteins are expressed at much lower levels in cell lines from the mouse and from most other species that have been examined Finnie et al., 1995; Walker et al., 1985) . The promoters for Ku expression have not been analysed, but the promoter of the human DNA-PK cs gene is typical of a ubiquitously expressed housekeeping gene (Connelly et al., 1998) . Mice and murine cell lines defective for any of the three DNA-PK subunits are de®cient in the repair of DSBs and are hypersensitive to ionizing radiation, as are human and equine cell lines that are de®cient or defective in DNA-PK cs (Lees-Miller et al., 1995; Shin et al., 1997) . Accordingly, we anticipated that DNA-PK would be uniformly expressed in most, if not all, human tissues. To test this hypothesis, we undertook the ®rst comprehensive survey of DNA-PK expression in normal and malignant human tissues.
Surprisingly, at least two components of DNA-PK, DNA-PK cs and Ku80, appear to be dierentially expressed among dierent human tissues and cell types. DNA-PK protein expression appears to be modulated at least at two levels. First, we observed dierences in the levels of DNA-PK cs and Ku80 expression among dierent tissues, with relatively high expression in neural cells (e.g. brain cortex, autonomic nervous system) and reproductive tissues (e.g. testis, Table 1 ), moderate levels of expression in epithelial cells from the majority of tissues, and low or no detectable expression in a few tissues (e.g. resting breast, liver, Table 1 ). The lack of observed expression may re¯ect limitations in assay sensitivity; thus, DNA-PK cs and Ku80 may well be expressed in apparently negative cells in human tissues at levels comparable to or even above their expression levels in mouse cells. Second, for most tissues, DNA-PK cs expression varied between individual cells of the same type within a given tissue. For example, approximately half the neurons and glial cells in the gray matter of the brain strongly expressed DNA-PK cs and Ku80, while another half were apparently negative for both proteins. In contrast, virtually all the ganglion and Schwann cells of the autonomic nervous system of the plexus myentericus strongly expressed both Ku80 and DNA-PK cs (Table  1) . Typically, fewer stromal cells than epithelial cells in a given tissue strongly expressed both proteins, although considerable variation between tissues was observed. Others reported lower levels of DNA-PK in quiescent and senescent human ®broblasts in culture compared to actively growing early passage or transformed cells, suggesting that DNA-PK levels may depend on the state of proliferation (Salminen et al., 1997) . Figure 5 Expression of DNA-PK mRNA in selected human tissues. A blot containing polyA-selected RNAs from 50 dierent human tissues was probed sequentially with labeled oligonucleotides speci®c for DNA-PK cs , GAPDH, Ku80 or Ku70 mRNAs as described in Materials and methods. The amount of RNA detected relative to the amount of DNA-PK cs mRNA from the pituitary gland is shown for selected tissues; the average value for all tissues also is given (dashed line). Each RNA was detected in all tissues examined, and in no case did the amount of RNA observed dier from the average for that RNA by more than 3.5-fold
In contrast to the variation in protein expression, similar levels of mRNAs for DNA-PK cs , Ku80, and Ku70 were found in each of the 50 dierent human tissues that were examined ( Figure 5 ). By Northern blot analyses, Cai et al. (1994) observed similar results for Ku70 RNA from human brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas; Ku80 expression was somewhat more variable from tissue to tissue. Although we did not speci®cally examine Ku70 protein levels, stability of the Ku80 polypeptide is dependent on expression of Ku70 ; thus, for tissues that express Ku80, we anticipate that Ku70 is expressed at a similar level. On average, all tissues appeared to express about fourfold less DNA-PK cs mRNA than Ku, and about 50-fold less than GAPDH, consistent with relative estimates of the levels of these proteins in cultured human cells. Although a few tissues (e.g. pituitary, testis, and small intestine) expressed 1.5 ± 2-fold higher levels of DNA-PK cs and Ku mRNAs compared to a tissue-wide average, none of the tissues had RNAs levels more than threefold below the tissue-wide average. Furthermore, there was little if any correlation between the amounts of protein and mRNA. Although the levels of DNA-PK cs , Ku80, and Ku70 mRNAs were somewhat higher than average in the testis, consistent with the high protein levels observed for spermatogenic cells, RNA levels for all three genes were slightly below the average in the cerebral cortex. Normal, resting mammary gland and liver, both of which were negative for DNA-PK cs and Ku80 protein, expressed average amounts of DNA-PK cs , Ku70, and Ku80 mRNAs.
While we cannot rule out variations in expression at the mRNA level between individual cells, taken together, our data are most consistent with the modulation of DNA-PK cs and Ku protein expression in human tissues at the post-transcriptional and, most probably, post-translational level. The half-lives of both DNA-PK cs protein and mRNA in cultured human cells and in some human tissues is long compared to many cellular proteins and mRNAs. Ajmani et al. (1995) found that the apparent half-lives of DNA-PK cs and Ku mRNAs in the K562 human erythroleukemia cell line were greater than 5 days. Long half-lives also were observed in stimulated peripheral blood lymphocytes (PBLs); however, the analysis was complicated by the induction of apoptosis. In contrast, both DNA-PK cs and Ku protein were absent from neutrophils and were not synthesized in resting PBLs (Ajmani et al., 1995) . Galloway et al. (1998) measured a half-life of about 3 days for DNA-PK cs mRNA in the human glioblastoma cell line M059K. A consequence of the relatively long protein and mRNA half-lives and relatively low mRNA abundance is that reductions in the half-lives of either to more typical values (*1 day) would result in comparatively large changes in protein levels. Thus, we suggest that such dierences in half-life may account for part or all of the variation in the levels of DNA-PK cs and Ku80 expression we observed among dierent cells and tissues.
Regardless of the precise molecular mechanism(s) that account for modulation of DNA-PK levels, our results indicate that DNA-PK levels are subject to physiological regulation. Such regulation was most apparent in breast tissue, which was negative for both Ku80 and DNA-PK cs in the non-lactating state, but positive for both when stimulated, suggesting a role for hormonal regulation of DNA-PK expression. However, our earlier analysis of the DNA-PK cs promoter sequence revealed no obvious elements for hormonal regulation at the level of transcription (Connelly et al., 1998) . Again, these ®ndings are most consistent with regulation at a posttranscriptional level. In a like manner, as seen from Table 2 and Figure 3 , DNA-PK cs and Ku80 were relatively strongly expressed in immunoblasts in follicular germinal centers of tonsil and in lymph nodes but were much more weakly expressed in resting B cells in the mantle zone. Macrophages were uniformly negative for both DNA-PK cs and Ku80. Others reported that Ku70 and Ku80, but not DNA-PK cs , protein levels decreased modestly in a murine B lymphoblasts tissue culture system induced to dierentiate towards plasma cells (Grawunder et al., 1996) . More work clearly will be required to characterize the mechanisms by which DNA-PK expression and activity are regulated in these systems.
Our study has potential implications for cancer susceptibility and treatment. The genes for DNA-PK cs and Ku behave as tumor suppressor genes in mice, and animals defective for DNA-PK cs or Ku70 exhibit increased spontaneous frequencies of T-cell lymphomas (Jhappan et al., 1997; Li et al., 1998) . In spite of previous reports to the contrary, DNA-PK recently was shown to be necessary, but not sucient, to activate sequence-speci®c DNA binding by p53 (Woo et al., 1998) . Furthermore, Muller et al. (1998) recently reported that tumor cells from patients with B-cell chronic lymphocytic leukemia (B-CLL) that became resistant to nitrogen mustard chemotherapy have elevated levels of DNA-PK activity compared to naive tumor cells from the same patients; their results suggest that DNA-PK may be a critical rate-limiting factor for ensuring the survival of tumor cells exposed to DNA damage-inducing agents. These ®ndings, in turn, suggest that low levels of DNA-PK activity may be suboptimal for protecting genomes from the environmental insults that lead to genetic instability and cancer. Further studies will be required to determine if the levels of DNA-PK and other components in the DSB repair pathways in¯uence the cellular susceptibility to malignant transformation in humans and cure rates for cancer therapies.
Materials and methods

Cell lines and preparation of RNA
The M059J and M059K glioblastoma cell lines were obtained from J Allalunis-Turner, Cross Cancer Institute, Edmonton, Canada (Allalunis-Turner et al., 1993); RKO cells were obtained from Y Pommier, NIH. Cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum at 378C in a humidi®ed atmosphere with 5% CO 2 . M059J cells do not express DNA-PK cs mRNA and protein; M059K cells are wild-type for DNA-PK expression (Lees-Miller et al., 1995) . HeLa cells were grown in suspension as described (Lees-Miller and Anderson, 1989) . Total cell RNA was prepared from *10 7 cells using the TRIzol Reagent (Gibco/BRL Life Technologies), which is based on the methods of Chomczynski and Sacchi (1987) , according to the manufacturer's instructions.
Antibodies DNAPK cs was detected with AB-145 (available from Oncogene Research Products, Cambridge, MA, USA), a rabbit polyclonal serum that recognizes epitopes between amino acids 2015 and 2134 of the 4127 residue polypeptide (Connelly et al., 1996) , at 1 : 200 for immuno¯uorescence, or at 1 : 350 for immunohistochemistry. The 80 kDa subunit of the Ku autoantigen was detected with mouse monoclonal antibodies that recognize the human Ku80 subunit. Ku15 (Sigma Chemical Co.) is an IgG 1 that detects an epitope between amino acid residues 490 ± 707; for immunohistochemistry it was used at 1 : 350. S10B1 (Ajmani et al., 1995) , a gift from EA Hentrickson, is a IgG 1 that detects an epitope between amino acid residues 8 ± 221. Brca2 was detected with the rabbit polyclonal antibody (Ab-2) PC146 (Oncogene Research Products), and was used at 14 mg/ml for immunohistochemistry.
Immuno¯uorescence
Cells were grown on glass coverslips, washed with phosphatebuered saline (PBS), and ®xed for 10 min at room temperature in acetone : ethanol (1 : 1). The coverslips were incubated at room temperature for 15 min with 3% BSA to block non-speci®c sites, for 15 min with preimmune serum diluted 1/100 in PBS, then, where indicated, for 60 min with AB-145 diluted 1 : 200 in PBS, and ®nally for 60 min with a 1 : 3000 dilution of FITC-conjugated goat anti-rabbit IgG (Cappel Laboratories). Coverslips were washed three times in PBS after each step; the stained coverslips were then mounted to glass slides with Vectashield (Vector Laboratories) and examined with a Nikon Diaphot microscope equipped for epi¯uorescence. Images were photographed through a 406 objective lens using Kodak Gold 200 Color ®lm.
Source of tissue
All tissues came from the routine pathology archives of the Department of Pathology, University Hospital at SUNY Stony Brook and were collected during 1995 ± 1997. They represent random selections of paran blocks from a spectrum of organs. These include colon carcinoma, normal colon, normal pancreas, liver, prostate, kidney, endometrium, serous carcinoma of the uterus, female primary peritoneal carcinoma, ductal breast carcinoma, normal ovary, testis, epididymis, testicular seminoma, skin, normal and hyperplastic tonsil, lymph node, Burkitt's lymphoma, spleen, normal and hyperplastic thymus, normal brain, and glioblastoma multiforme. After biopsy or resection (except normal brain which was harvested at autopsy), the tissues were ®xed in 10% formalin for up to 18 h, and processed for light microscopy by standard methods.
Immunohistochemistry
The staining procedure was identical in all cases. Brie¯y, 4 mm paran sections were deparanized and optimal antigen retrieval was obtained by microwaving sections in 100 mM citric acid buer, pH 6.0 for 5 min six times. Sections then were treated with 0.3% H 2 O 2 /methanol to quench endogenous peroxidase activity. After blocking with 10% normal goat serum, sections were incubated at 48C overnight with primary antibody in 2% bovine serum albumin/phosphate buered saline. Biotinylated goat antimouse or goat anti-rabbit secondary antibodies and streptavidin/biotin complex were applied for 30 min each (ZYMED, San Francisco CA, USA), followed by 8 min incubation in diaminobenzidine substrate and extensive washing. Sections were lightly counter stained in hematoxylin and mounted under a coverslip. Only nuclear staining was considered positive. Sections were photographed with a Nikon photomicroscope.
